Assignee
ST JUDE CHILDRENS RES HOSPITAL INC
US·36 granted patents·58 pending applications·81 citations·filing 2014–2025
Top patents by PatentIndex Score
94 records- 0197US11873512B2Chimeric receptor with NKG2D specificity for use in cell therapy against cancer and infectious diseaseST JUDE CHILDRENS RES HOSPITAL INC·Filed 2020·Granted Jan 16, 2024·6 cites·19 claims
- 0297US10836999B2Chimeric receptor with NKG2D specificity for use in cell therapy against cancer and infectious diseaseST JUDE CHILDRENS RES HOSPITAL INC·Filed 2017·Granted Nov 17, 2020·13 cites·20 claims
- 0396US10829737B2Chimeric receptor with NKG2D specificity for use in cell therapy against cancer and infectious diseaseST JUDE CHILDRENS RES HOSPITAL INC·Filed 2017·Granted Nov 10, 2020·9 cites·24 claims
- 0496US10801012B2Chimeric receptor with NKG2D specificity for use in cell therapy against cancer and infectious diseaseST JUDE CHILDRENS RES HOSPITAL INC·Filed 2017·Granted Oct 13, 2020·9 cites·21 claims
- 0596US10774309B2Natural killer cell immunotherapy for treating cancerST JUDE CHILDRENS RES HOSPITAL INC·Filed 2017·Granted Sep 15, 2020·9 cites·11 claims
- 0696US10538739B2Chimeric receptor with NKG2D specificity for use in cell therapy against cancer and infectious diseaseST JUDE CHILDRENS RES HOSPITAL INC·Filed 2016·Granted Jan 21, 2020·9 cites·18 claims
- 0795US11673937B2Methods for expanding immune cellsST JUDE CHILDRENS RES HOSPITAL INC·Filed 2017·Granted Jun 13, 2023·7 cites·15 claims
- 0887US11643682B2Method for nucleic acid amplificationST JUDE CHILDRENS RES HOSPITAL INC·Filed 2022·Granted May 9, 2023·2 cites·19 claims
- 0987US2024092862A1Methods for expanding immune cellsST JUDE CHILDRENS RES HOSPITAL INC·Filed 2023·Application pending·0 cites
- 1087US2024191196A1Chimeric receptor with nkg2d specificity for use in cell therapy against cancer and infectious diseaseST JUDE CHILDRENS RES HOSPITAL INC·Filed 2023·Application pending·0 cites
- 1185US11905553B2Method for nucleic acid amplificationST JUDE CHILDRENS RES HOSPITAL INC·Filed 2019·Granted Feb 20, 2024·5 cites·20 claims
- 1283US11547709B2Methods of treating disorders associated with castorST JUDE CHILDRENS RES HOSPITAL INC·Filed 2018·Granted Jan 10, 2023·2 cites·19 claims
- 1383US11103597B2Nucleic acid molecules containing spacers outside ITRST JUDE CHILDRENS RES HOSPITAL INC·Filed 2016·Granted Aug 31, 2021·2 cites·33 claims
- 1482US12559794B2Method for nucleic acid amplificationST JUDE CHILDRENS RES HOSPITAL INC·Filed 2024·Granted Feb 24, 2026·0 cites·30 claims
- 1581US12516051B1Small molecule degraders and fluorescent probes of PXRST JUDE CHILDRENS RES HOSPITAL INC·Filed 2024·Granted Jan 6, 2026·0 cites·15 claims
- 1681US11891378B2Small molecule modulators of pantothenate kinasesST JUDE CHILDRENS RES HOSPITAL INC·Filed 2018·Granted Feb 6, 2024·2 cites·3 claims
- 1779US10441601B2Method for treating schizophreniaST JUDE CHILDRENS RES HOSPITAL INC·Filed 2016·Granted Oct 15, 2019·2 cites·11 claims
- 1877US12545663B2Small molecule modulators of pantothenate kinasesST JUDE CHILDRENS RES HOSPITAL INC·Filed 2023·Granted Feb 10, 2026·0 cites·14 claims
- 1975US2024035080A1Method for nucleic acid amplificationST JUDE CHILDRENS RES HOSPITAL INC·Filed 2023·Application pending·0 cites
- 2075US2026092058A1Small Molecule Degraders and Fluorescent Probes of PXRST JUDE CHILDRENS RES HOSPITAL INC·Filed 2024·Application pending·0 cites
- 2173US2025090526A1Methods of treating disorders associated with castorST JUDE CHILDRENS RES HOSPITAL INC·Filed 2024·Application pending·0 cites
- 2272US12454519B2Substituted N-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)arylsulfonamide analogs as modulators of cereblon proteinST JUDE CHILDRENS RES HOSPITAL INC·Filed 2023·Granted Oct 28, 2025·0 cites·26 claims
- 2371US10266544B2Aryl substituted aminomethyl spectinomycin analogs as antibacterial agentsST JUDE CHILDRENS RES HOSPITAL INC·Filed 2014·Granted Apr 23, 2019·4 cites·31 claims
- 2471US2023310382A1Methods and formulations for treatment of spinobulbar muscular atrophyST JUDE CHILDRENS RES HOSPITAL INC·Filed 2023·Application pending·0 cites
- 2569US2023321092A1Methods of treating disorders associated with castorST JUDE CHILDRENS RES HOSPITAL INC·Filed 2022·Application pending·0 cites
- 2667US12453783B2Nucleic acid molecules containing spacers and methods of use thereofST JUDE CHILDRENS RES HOSPITAL INC·Filed 2021·Granted Oct 28, 2025·0 cites·12 claims
- 2766US10920272B2High-throughput method for characterizing the genome-wide activity of editing nucleases in vitroST JUDE CHILDRENS RES HOSPITAL INC·Filed 2019·Granted Feb 16, 2021·0 cites·21 claims
- 2866US2025302821A1Synergistic antifungal composition and methodST JUDE CHILDRENS RES HOSPITAL INC·Filed 2023·Application pending·0 cites
- 2965US12454518B2Substituted N-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)arylsulfonamide analogs as modulators of cereblon proteinST JUDE CHILDRENS RES HOSPITAL INC·Filed 2022·Granted Oct 28, 2025·0 cites·29 claims
- 3064US2025354171A1Erythroid-specific promoter and method of use thereofST JUDE CHILDRENS RES HOSPITAL INC·Filed 2025·Application pending·0 cites
- 3163US11946053B2Methods for overcoming glucocorticoid resistance and for determining glucocorticoid resistance potential in cancerST JUDE CHILDRENS RES HOSPITAL INC·Filed 2019·Granted Apr 2, 2024·0 cites·22 claims
- 3263US11371095B2High-throughput method for characterizing the genome-wide activity of editing nucleases in vitro (Change-Seq)ST JUDE CHILDRENS RES HOSPITAL INC·Filed 2021·Granted Jun 28, 2022·0 cites·26 claims
- 3363US2025325697A1Targeting Neo Splice Sites and Cryptic Exons in the Treatment of CancerST JUDE CHILDRENS RES HOSPITAL INC·Filed 2023·Application pending·0 cites
- 3463US2025223552A1Method for preparing t cells for adoptive t cell therapyST JUDE CHILDRENS RES HOSPITAL INC·Filed 2023·Application pending·0 cites
- 3562US11707449B2Methods and formulations for treatment of spinobulbar muscular atrophyST JUDE CHILDRENS RES HOSPITAL INC·Filed 2018·Granted Jul 25, 2023·0 cites·19 claims
- 3662US2024139315A1Compositions and methods for prevention and treatment of hearing lossST JUDE CHILDRENS RES HOSPITAL INC·Filed 2023·Application pending·0 cites
- 3762US2024277810A1Interferons and nuclear export inhibitors for use in methods of treating cancerST JUDE CHILDRENS RES HOSPITAL INC·Filed 2022·Application pending·0 cites
- 3862US2025257388A2Pre-effector car-t cell gene signaturesST JUDE CHILDRENS RES HOSPITAL INC·Filed 2022·Application pending·0 cites
- 3962US2025066852A1Kit and Method for Analyzing T Cell Receptors from Single T CellsST JUDE CHILDRENS RES HOSPITAL INC·Filed 2022·Application pending·0 cites
- 4061US2018118845A1Chimeric Receptors with 4-1BB Stimulatory Signaling DomainST JUDE CHILDRENS RES HOSPITAL INC·Filed 2017·Application pending·0 cites
- 4160US2025122166A1Substituted n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)methyl)benzamide analogs as modulators of cereblon proteinST JUDE CHILDRENS RES HOSPITAL INC·Filed 2022·Application pending·0 cites
- 4260US2025161414A1Method for improving auditory perception using a vipr1 inhibitorST JUDE CHILDRENS RES HOSPITAL INC·Filed 2023·Application pending·0 cites
- 4360US2025122185A1Compositions and methods comprising substituted n-(2-chloro-6-methylphenyl)-2-((6-(6-membered heterocycloalkyl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide analoguesST JUDE CHILDRENS RES HOSPITAL INC·Filed 2022·Application pending·0 cites
- 4459US2024018230A1Methods for treating or modulating an inflammatory responseST JUDE CHILDRENS RES HOSPITAL INC·Filed 2021·Application pending·0 cites
- 4559US2025064933A1Chimeric antigen receptors comprising a pdz binding motifST JUDE CHILDRENS RES HOSPITAL INC·Filed 2022·Application pending·0 cites
- 4659US2025283110A1Methods and compositions for transduction of nk cellsST JUDE CHILDRENS RES HOSPITAL INC·Filed 2022·Application pending·0 cites
- 4759US2026078451A1Diagnosis and Treatment of Pediatric MalignanciesST JUDE CHILDRENS RES HOSPITAL INC·Filed 2025·Application pending·0 cites
- 4858US2020016189A1Method for treating schizophreniaST JUDE CHILDRENS RES HOSPITAL INC·Filed 2019·Application pending·0 cites
- 4958US2025346649A1Zip cytokine receptorsST JUDE CHILDRENS RES HOSPITAL INC·Filed 2022·Application pending·0 cites
- 5058US2023310559A1Use of Amylase or Maltose to Treat or Prevent NeurodegenerationST JUDE CHILDRENS RES HOSPITAL INC·Filed 2021·Application pending·0 cites
Showing the top 50 of 94 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when ST JUDE CHILDRENS RES HOSPITAL INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →